These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 9468272

  • 21. [Morphological features of cancer in chronic non-specific ulcerative colitis].
    Kapuller LL.
    Arkh Patol; 1999; 61(6):28-32. PubMed ID: 10664817
    [Abstract] [Full Text] [Related]

  • 22. Colorectal cancer complicating ulcerative colitis: an institutional series.
    Fracasso P, Assisi D, Stigliano V, Casale V.
    J Exp Clin Cancer Res; 1999 Mar; 18(1):29-32. PubMed ID: 10374673
    [Abstract] [Full Text] [Related]

  • 23. Dysplasia and cancer in ulcerative colitis.
    Desaint B, Legendre C, Florent C.
    Hepatogastroenterology; 1989 Aug; 36(4):219-26. PubMed ID: 2680859
    [No Abstract] [Full Text] [Related]

  • 24. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
    Matsuda K, Watanabe H, Ajioka Y, Kobayashi M, Saito H, Sasaki M, Yasuda K, Kuwabara A, Nishikura K, Muto T.
    J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
    [Abstract] [Full Text] [Related]

  • 25. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
    Yoshida T, Mikami T, Mitomi H, Okayasu I.
    J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
    [Abstract] [Full Text] [Related]

  • 26. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis.
    Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, Bronner MP.
    Cancer Res; 1999 Oct 15; 59(20):5148-53. PubMed ID: 10537290
    [Abstract] [Full Text] [Related]

  • 27. [Dysplasia in ulcerative colitis].
    Werner M, Mueller E.
    Verh Dtsch Ges Pathol; 1999 Oct 15; 83():122-9. PubMed ID: 10714202
    [Abstract] [Full Text] [Related]

  • 28. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
    Haapamäki MM, Häggblom JO, Grönroos JM, Pekkala E, Alanen K, Nevalainen TJ.
    Hepatogastroenterology; 1999 Oct 15; 46(28):2273-7. PubMed ID: 10521980
    [Abstract] [Full Text] [Related]

  • 29. [Frequency of proximal colonic extension of distal ulcerative colitis].
    Karoui S, Kallel L, Dahmani Z, Boubaker J, Filali A.
    Tunis Med; 2007 Aug 15; 85(8):669-72. PubMed ID: 18254289
    [Abstract] [Full Text] [Related]

  • 30. Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.
    Yoshida T, Matsumoto N, Mikami T, Okayasu I.
    Br J Cancer; 2004 Sep 13; 91(6):1081-8. PubMed ID: 15292938
    [Abstract] [Full Text] [Related]

  • 31. Ulcerative colitis and colonic lymphoma: a theoretical link.
    Khan S, Anderson GK, Eppstein AC, Eggenberger JC, Margolin DA.
    Am Surg; 2001 Jul 13; 67(7):654-6. PubMed ID: 11450782
    [Abstract] [Full Text] [Related]

  • 32. Ulcerative colitis and carcinoma of the colon.
    Brooke BN.
    J R Coll Surg Edinb; 1969 Sep 13; 14(5):274-8. PubMed ID: 5346559
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical and histopathological findings in malignant transformation of idiopathic hemorrhagic rectocolitis].
    Colì G, Lapilli A, Vecchi R, Piccinni L.
    Minerva Chir; 1984 Sep 30; 39(18):1199-204. PubMed ID: 6504361
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.
    Lashner BA, Shapiro BD, Husain A, Goldblum JR.
    Am J Gastroenterol; 1999 Feb 30; 94(2):456-62. PubMed ID: 10022646
    [Abstract] [Full Text] [Related]

  • 35. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.
    Fogt F, Zhuang Z, Poremba C, Dockhorn-Dworniczak B, Vortmeyer A.
    Oncol Rep; 1998 Feb 30; 5(2):477-80. PubMed ID: 9468583
    [Abstract] [Full Text] [Related]

  • 36. Development of colonic neoplasms and expressions of p53 and p21 proteins in experimental colitis of mice induced by dextran sulfate sodium.
    Takesue F, Korenaga D, Yao T, Kabashima A, Sugimachi K.
    J Exp Clin Cancer Res; 2001 Sep 30; 20(3):413-8. PubMed ID: 11718223
    [Abstract] [Full Text] [Related]

  • 37. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R, Lindberg J, Rutegård J, Palmqvist R.
    APMIS; 2007 Nov 30; 115(11):1219-26. PubMed ID: 18092953
    [Abstract] [Full Text] [Related]

  • 38. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 39. Ulcerative colitis in the Jewish population of Tel-Aviv Uafo. II: The rarity of malignant degeneration.
    Gilat T, Zemishlany Z, Ribak J, Bennaroya Y, Lilos P.
    Gastroenterology; 1974 Nov 29; 67(5):933-8. PubMed ID: 4426494
    [No Abstract] [Full Text] [Related]

  • 40. The fate of low grade dysplasia in ulcerative colitis.
    Ullman TA, Loftus EV, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 2002 Apr 29; 97(4):922-7. PubMed ID: 12008669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.